BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7881744)

  • 1. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine.
    Benwell ME; Balfour DJ; Birrell CE
    Br J Pharmacol; 1995 Jan; 114(2):454-60. PubMed ID: 7881744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine.
    Benwell ME; Balfour DJ; Khadra LF
    Clin Investig; 1994 Feb; 72(3):233-9. PubMed ID: 8012168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity.
    Benwell ME; Balfour DJ
    Br J Pharmacol; 1992 Apr; 105(4):849-56. PubMed ID: 1504716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
    Hildebrand BE; Svensson TH
    J Neural Transm (Vienna); 2000; 107(8-9):861-72. PubMed ID: 11041268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats.
    Benwell ME; Balfour DJ
    Br J Pharmacol; 1998 Nov; 125(6):1115-9. PubMed ID: 9863636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
    Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
    Clarke PB; Fu DS; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1988 Aug; 246(2):701-8. PubMed ID: 3136244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibogaine and the dopaminergic response to nicotine.
    Maisonneuve IM; Mann GL; Deibel CR; Glick SD
    Psychopharmacology (Berl); 1997 Feb; 129(3):249-56. PubMed ID: 9084063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.
    Tammimäki A; Pietilä K; Raattamaa H; Ahtee L
    Eur J Pharmacol; 2006 Feb; 531(1-3):118-25. PubMed ID: 16442094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
    Nisell M; Nomikos GG; Svensson TH
    Synapse; 1994 Jan; 16(1):36-44. PubMed ID: 8134899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
    Salminen O; Seppä T; Gäddnäs H; Ahtee L
    J Neurosci; 1999 Sep; 19(18):8145-51. PubMed ID: 10479714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study.
    Brazell MP; Mitchell SN; Gray JA
    Neuropharmacology; 1991 Aug; 30(8):823-33. PubMed ID: 1685769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens.
    Damsma G; Day J; Fibiger HC
    Eur J Pharmacol; 1989 Sep; 168(3):363-8. PubMed ID: 2479574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization.
    Reid MS; Fox L; Ho LB; Berger SP
    Synapse; 2000 Feb; 35(2):129-36. PubMed ID: 10611638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats.
    Shoaib M; Shippenberg TS
    Psychopharmacology (Berl); 1996 Dec; 128(4):343-50. PubMed ID: 8986004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurochemical components of nicotine sensitization following 15-day pretreatment: studies on contextual conditioning.
    Reid MS; Ho LB; Berger SP
    Behav Pharmacol; 1998 Mar; 9(2):137-48. PubMed ID: 10065933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine.
    Cadoni C; Di Chiara G
    Eur J Pharmacol; 2000 Jan; 387(3):R23-5. PubMed ID: 10650185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nicotine on locomotor activity and dopamine overflow in the alcohol-preferring AA and alcohol-avoiding ANA rats.
    Kiianmaa K; Tuomainen P; Makova N; Seppä T; Mikkola JA; Petteri Piepponen T; Ahtee L; Hyytiä P
    Eur J Pharmacol; 2000 Nov; 407(3):293-302. PubMed ID: 11068025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis.
    Reid MS; Ho LB; Berger SP
    Psychopharmacology (Berl); 1996 Aug; 126(4):301-10. PubMed ID: 8878346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
    Janhunen S; Ahtee L
    Eur J Pharmacol; 2004 Jun; 494(2-3):167-77. PubMed ID: 15212971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.